DCGI

First-time-in-India approval strengthens Akums’ presence in the growing cardiovascular therapeutics segment

Industry welcome the initiative, with industry bodies calling for structured dialogue on regulatory requirements and…

India is building a future-ready drug regulatory framework to accelerate healthcare innovation while maintaining the highest…

QDENGA, now approved in 43 countries, including India, is designed to protect against all four dengue virus serotypes

In a significant move to uphold ethical pharma practices and safeguard public health, the Drugs Controller General of India has…

While we agree that “what got us here (an affordable generics powerhouse) will not get us there (a leader in pharma innovation)”,…

Even as India’s biggest pharma companies pursue biosimilars, product recalls related to manufacturing defects threaten to queer…

At Global Digital Health Summit (GDHS) 2025, Dr. Rajeev Raghuvanshi, Drugs Controller General of India (DCGI) emphasised on the…

The drug regulator has permitted the temporary affixing of stickers to reflect revised Maximum Retail Prices (MRPs) on certain…

The outer layer provides rapid relief from nausea, while the inner core maintains a prolonged action